Literature DB >> 28007983

Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.

Jacob D Aguirre1, Karen M Dunkerley1, Pascal Mercier1, Gary S Shaw2.   

Abstract

Mutations in PARK2 and PARK6 genes are responsible for the majority of hereditary Parkinson's disease cases. These genes encode the E3 ubiquitin ligase parkin and the protein kinase PTEN-induced kinase 1 (PINK1), respectively. Together, parkin and PINK1 regulate the mitophagy pathway, which recycles damaged mitochondria following oxidative stress. Native parkin is inactive and exists in an autoinhibited state mediated by its ubiquitin-like (UBL) domain. PINK1 phosphorylation of serine 65 in parkin's UBL and serine 65 of ubiquitin fully activate ubiquitin ligase activity; however, a structural rationale for these observations is not clear. Here, we report the structure of the phosphorylated UBL domain from parkin. We find that destabilization of the UBL results from rearrangements to hydrophobic core packing that modify its structure. Altered surface electrostatics from the phosphoserine group disrupt its intramolecular association, resulting in poorer autoinhibition in phosphorylated parkin. Further, we show that phosphorylation of both the UBL domain and ubiquitin are required to activate parkin by releasing the UBL domain, forming an extended structure needed to facilitate E2-ubiquitin binding. Together, the results underscore the importance of parkin activation by the PINK1 phosphorylation signal and provide a structural picture of the unraveling of parkin's ubiquitin ligase potential.

Entities:  

Keywords:  E3 ligase; Parkinson’s disease; conformational change; phosphorylation; ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 28007983      PMCID: PMC5240717          DOI: 10.1073/pnas.1613040114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.

Authors:  Koji Yamano; Bruno B Queliconi; Fumika Koyano; Yasushi Saeki; Takatsugu Hirokawa; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

5.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

6.  Autoregulation of Parkin activity through its ubiquitin-like domain.

Authors:  Viduth K Chaugule; Lynn Burchell; Kathryn R Barber; Ateesh Sidhu; Simon J Leslie; Gary S Shaw; Helen Walden
Journal:  EMBO J       Date:  2011-06-21       Impact factor: 11.598

7.  Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.

Authors:  Helen I Woodroof; Joe H Pogson; Mike Begley; Lewis C Cantley; Maria Deak; David G Campbell; Daan M F van Aalten; Alexander J Whitworth; Dario R Alessi; Miratul M K Muqit
Journal:  Open Biol       Date:  2011-11       Impact factor: 6.411

8.  Identification of histidine tautomers in proteins by 2D 1H/13C(delta2) one-bond correlated NMR.

Authors:  James L Sudmeier; Elizabeth M Bradshaw; Kristin E Coffman Haddad; Regina M Day; Craig J Thalhauser; Peter A Bullock; William W Bachovchin
Journal:  J Am Chem Soc       Date:  2003-07-16       Impact factor: 15.419

9.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

10.  Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism.

Authors:  David M Duda; Jennifer L Olszewski; Jonathan P Schuermann; Igor Kurinov; Darcie J Miller; Amanda Nourse; Arno F Alpi; Brenda A Schulman
Journal:  Structure       Date:  2013-05-23       Impact factor: 5.006

View more
  35 in total

1.  UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.

Authors:  Sungjin Park; Peter K Foote; David T Krist; Sarah E Rice; Alexander V Statsyuk
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

2.  Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.

Authors:  Peter K Foote; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2018-07-31

Review 3.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

Review 4.  Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.

Authors:  M A Artyukhova; Y Y Tyurina; C T Chu; T M Zharikova; H Bayır; V E Kagan; P S Timashev
Journal:  Free Radic Biol Med       Date:  2019-06-12       Impact factor: 7.376

Review 5.  Building and decoding ubiquitin chains for mitophagy.

Authors:  J Wade Harper; Alban Ordureau; Jin-Mi Heo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-23       Impact factor: 94.444

Review 6.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

Review 7.  Mitochondrial damage & lipid signaling in traumatic brain injury.

Authors:  Andrew M Lamade; Tamil S Anthonymuthu; Zachary E Hier; Yuan Gao; Valerian E Kagan; Hülya Bayır
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 8.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

9.  Structure of PINK1 in complex with its substrate ubiquitin.

Authors:  Alexander F Schubert; Christina Gladkova; Els Pardon; Jane L Wagstaff; Stefan M V Freund; Jan Steyaert; Sarah L Maslen; David Komander
Journal:  Nature       Date:  2017-10-30       Impact factor: 49.962

10.  Kanglexin delays heart aging by promoting mitophagy.

Authors:  Hui-Min Li; Xin Liu; Zi-Yu Meng; Lei Wang; Li-Min Zhao; Hui Chen; Zhi-Xia Wang; Hao Cui; Xue-Qing Tang; Xiao-Han Li; Wei-Na Han; Xue Bai; Yuan Lin; Heng Liu; Yong Zhang; Bao-Feng Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.